The government’s flagship 18-week referral to treatment target (RTT) is already under threat from a predicted rise in demand and the soaring cost of healthcare, according to global management and technology consultancy BearingPoint.The company carried out a survey involving 80 primary care trusts (PCTs), acute trusts and strategic health authorities (SHAs). It found that additional…